Literature DB >> 21435432

Phagocytic clearance in neurodegeneration.

Jennifer D Sokolowski1, James W Mandell.   

Abstract

The cellular and molecular mechanisms of phagocytic clearance of apoptotic cells and debris have been intensely studied in invertebrate model organisms and in the mammalian immune system. This evolutionarily conserved process serves multiple purposes. Uncleared debris from dying cells or aggregated proteins can be toxic and may trigger exaggerated inflammatory responses. Even though apoptotic cell death and debris accumulation are key features of neurodegenerative diseases, relatively little attention has been paid to this important homeostatic function in the central nervous system (CNS). This review attempts to summarize our knowledge of phagocytic clearance in the CNS, with a focus on retinal degeneration, forms of which are caused by mutations in genes within known phagocytic pathways, and on Alzheimer's disease (AD). Interest in phagocytic clearance mechanisms in AD was stimulated by the discovery that immunization could promote phagocytic clearance of amyloid-β; however, much less is known about clearance of neuronal and synaptic corpses in AD and other neurodegenerative diseases. Because the regulation of phagocytic activity is intertwined with cytokine signaling, this review also addresses the relationships among CNS inflammation, glial responses, and phagocytic clearance.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435432      PMCID: PMC3078427          DOI: 10.1016/j.ajpath.2010.12.051

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  99 in total

1.  Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.

Authors:  Pritam Das; Victor Howard; Nicole Loosbrock; Dennis Dickson; M Paul Murphy; Todd E Golde
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

2.  Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid.

Authors:  Rodrigo Alarcón; Carolina Fuenzalida; Marcos Santibáñez; Rommy von Bernhardi
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

3.  Role of alpha2-macroglobulin in regulating amyloid beta-protein neurotoxicity: protective or detrimental factor?

Authors:  C Fabrizi; R Businaro; G M Lauro; L Fumagalli
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

4.  Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.

Authors:  M Tschernutter; F C Schlichtenbrede; S Howe; K S Balaggan; P M Munro; J W B Bainbridge; A J Thrasher; A J Smith; R R Ali
Journal:  Gene Ther       Date:  2005-04       Impact factor: 5.250

5.  Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.

Authors:  M Broe; C E Shepherd; E A Milward; G M Halliday
Journal:  Acta Neuropathol       Date:  2001-06       Impact factor: 17.088

Review 6.  Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis.

Authors:  Joshua J Gagne; Melinda C Power
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

7.  Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

Authors:  Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Dora Games; Peter Seubert; Dale Schenk; Bradley T Hyman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

Authors:  Donna M Wilcock; Amyn Rojiani; Arnon Rosenthal; Gil Levkowitz; Sangeetha Subbarao; Jennifer Alamed; David Wilson; Nedda Wilson; Melissa J Freeman; Marcia N Gordon; Dave Morgan
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

9.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

10.  C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.

Authors:  Deborah A Fraser; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2009-11-16       Impact factor: 5.372

View more
  60 in total

Review 1.  Microglial cell origin and phenotypes in health and disease.

Authors:  Kaoru Saijo; Christopher K Glass
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  Immune aging and challenges for immune protection of the graying population.

Authors:  Abbe N Vallejo
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

3.  Elevation of GM2 ganglioside during ethanol-induced apoptotic neurodegeneration in the developing mouse brain.

Authors:  Mitsuo Saito; Goutam Chakraborty; Relish Shah; Rui-Fen Mao; Asok Kumar; Dun-Sheng Yang; Kostantin Dobrenis; Mariko Saito
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

4.  Dying Neurons Utilize Innate Immune Signaling to Prime Glia for Phagocytosis during Development.

Authors:  Colleen N McLaughlin; Jahci J Perry-Richardson; Jaeda C Coutinho-Budd; Heather T Broihier
Journal:  Dev Cell       Date:  2019-02-07       Impact factor: 12.270

Review 5.  New advances on glial activation in health and disease.

Authors:  Kim Mai Lee; Andrew G MacLean
Journal:  World J Virol       Date:  2015-05-12

6.  Ganglioside accumulation in activated glia in the developing brain: comparison between WT and GalNAcT KO mice.

Authors:  Mariko Saito; Gusheng Wu; Maria Hui; Kurt Masiello; Kostantin Dobrenis; Robert W Ledeen; Mitsuo Saito
Journal:  J Lipid Res       Date:  2015-06-10       Impact factor: 5.922

Review 7.  It's a cell-eat-cell world: autophagy and phagocytosis.

Authors:  Elizabeth A Oczypok; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2013-01-29       Impact factor: 4.307

8.  Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.

Authors:  Raffaele Ferrari; Yunpeng Wang; Jana Vandrovcova; Sebastian Guelfi; Aree Witeolar; Celeste M Karch; Andrew J Schork; Chun C Fan; James B Brewer; Parastoo Momeni; Gerard D Schellenberg; William P Dillon; Leo P Sugrue; Christopher P Hess; Jennifer S Yokoyama; Luke W Bonham; Gil D Rabinovici; Bruce L Miller; Ole A Andreassen; Anders M Dale; John Hardy; Rahul S Desikan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-11-29       Impact factor: 10.154

9.  Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.

Authors:  Janet Hsu; Jeff Rappaport; Silvia Muro
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

Review 10.  Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease.

Authors:  Sang Myun Park; Kwang Soo Kim
Journal:  Prion       Date:  2012-11-15       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.